Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term B-cell lymphoma
ADR ID BADD_A00407
ADR Hierarchy
01      Blood and lymphatic system disorders
01.15      Lymphomas non-Hodgkin's B-cell
01.15.01      B-cell lymphomas NEC
01.15.01.001      B-cell lymphoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.28      Lymphomas non-Hodgkin's B-cell
16.28.01      B-cell lymphomas NEC
16.28.01.001      B-cell lymphoma
Description A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes. [MeSH]
MedDRA Code 10003899
MeSH ID D016393; D008224
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
B-cell lymphoma | B-cell lymphoma NOS | Nodular lymphoma | B-cell non-Hodgkin's lymphoma | Lymphoma, B-Cell | Lymphoma, B Cell | B-Cell Lymphoma | B Cell Lymphoma | B-Cell Lymphomas | Lymphomas, B-Cell
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02236Tofacitinib0.000723%
BADD_D02342Vedolizumab--
BADD_D02344Vemurafenib0.000168%
BADD_D02345Venetoclax0.000392%
BADD_D02392Zoledronic acid--
BADD_D02464Fingolimod0.001736%
The 2th Page    First    Pre   2    Total 2 Pages